Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk.
Dr Reddy’s gets 30 days to sell ‘Olymviq’ stock in Novo trademark case
Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk.